PHOENIXVILLE, PA — Facet Life Sciences, a firm specializing in regulatory guidance for life science companies, has announced its partnership with Nucleus, a leader in diagnostic and therapeutic radiopharmaceuticals. Facet will serve as Nucleus’ official regulatory partner, providing expertise in U.S. regulatory affairs and development support for innovative products in the radiopharmaceutical sector. Ken VanLuvanee, President & CEO of Facet Life…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.